Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - Mawson Infrastructure Group Inc. | f8k021518_wizepharmainc.htm |
Exhibit 16.1
15/02/2018
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated February 15, 2018 of Wize Pharma, Inc. (formerly OphthaliX, Inc.) and are in agreement with the statements contained in the specify paragraphs therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
| Tel Aviv, Israel | /s/ KOST, FORER, GABBAY & KASIERER | |
| February 15, 2018 | KOST, FORER, GABBAY & KASIERER | |
| A Member of EY Global |